With "Innovate Genome＂ as its vision, TOOLGEN is a bioventure looking to develop treatments and agricultural products based on gene editing technology. The company owns the world-renowned CRISPR/Cas9 gene editing scissor platform. TOOLGEN is focusing on genes and cell-level treatments.
http://www.toolgen.com
http://www.toolgen.com
Investors 1
| Date | Name | Website |
| - | KTB Networ... | ktbnetwork... |
Mentions in press and media 3
| Date | Title | Description |
| 11.06.2026 | ToolGen Opens Advanced Field Testing Facility in Osong, Completing 'Bench-to-Field' Commercialization Platform for Global SAF and Industrial Crop Markets | Establishes a regulatory-compliant, state-of-the-art Genome-Edited (GE) Crop Field Testing Facility to accelerate global commercialization. Enables comprehensive field evaluation of a diversified crop portfolio, including drought tolerance,... |
| 24.11.2025 | ToolGen and GenEditBio Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics | Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL,... |
| 24.11.2025 | GenEditBio and ToolGen Enter Strategic Cross-License Agreement to Accelerate Development of Innovative Genome-Editing Therapeutics | Integrates ToolGen's best-in-class CRISPR-Cas9 platform with GenEditBio's industry-leading lipid nanoparticle (LNP) delivery technology Pursues a "once-and-done" treatment paradigm for diseases with high unmet medical needs SEOUL,... |